¿Es la mitomicina C superior al 5-fluorouracilo como antimetabolito en la trabeculectomía para el glaucoma?

Pimentel, E; Schmidt, J.
Medwave ; 18(1): e7138, 2018.
Artículo en Inglés, Español | LILACS | ID: biblio-909780

Documentos relacionados

  1. Is mytomicyn better than 5-fluorouracil as antimetabolite in trabeculectomy for glaucoma?
  2. A Novel Method for the Delivery of Antimetabolites During Glaucoma Surgery.
  3. Enhanced trabeculectomy in a UK district general hospital setting: is selective use of 5-fluorouracil all that is required?
  4. Comparison of 90-s versus 5-min intraoperative 5-fluorouracil in trabeculectomy.
  5. Antimetabolite application technique in trabeculectomy surgery.
  6. The Effects of Bevacizumab in Augmenting Trabeculectomy for Glaucoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
  7. Review of consecutive phacotrabeculectomies supplemented with early needle revision and antimetabolites.
  8. Short term experience with "modern" trabeculectomy augmented with intraoperative antimetabolites.
  9. Mitomycin C and 5-fluorouracil antimetabolite therapy for pediatric glaucoma filtration surgery.
  10. Results of intraoperative 5-fluorouracil or lower dose mitomycin-C administration on initial trabeculectomy surgery.